NEOPHYR

This brand name is authorized in Spain, Croatia, Ireland, Romania

Active ingredients

The drug NEOPHYR contains one active pharmaceutical ingredient (API):

1 Nitric oxide (NO) UNII 31C4KY9ESH - NITRIC OXIDE

Nitric oxide is a compound produced by many cells of the body. It relaxes vascular smooth muscle by binding to the haeme moiety of cytosolic guanylate cyclase. When inhaled, nitric oxide produces selective pulmonary vasodilation. Read about Nitric oxide (NO)

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NEOPHYR Medicinal gas, compressed	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R07AX01	Nitric oxide	R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AX Other respiratory system products
Discover more medicines within R07AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 81848
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-455904640
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W60115001, W60117001, W60118001, W60118002